BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghasemi-Chaleshtari M, Kiaie SH, Irandoust M, Karami H, Nabi Afjadi M, Ghani S, Aghaei Vanda N, Ghaderi Sede MJ, Ahmadi A, Masjedi A, Hassannia H, Atyabi F, Hojjat-Farsangi M, Namdar A, Ghalamfarsa G, Jadidi-Niaragh F. Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses. J Cell Physiol 2020;235:10068-80. [PMID: 32488862 DOI: 10.1002/jcp.29822] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Karoon Kiani F, Izadi S, Ansari Dezfouli E, Ebrahimi F, Mohammadi M, Chalajour H, Mortazavi Bulus M, Nasr Esfahani M, Karpisheh V, Mahmoud Salehi Khesht A, Abbaszadeh-Goudarzi K, Soleimani A, Gholizadeh Navashenaq J, Ahmadi M, Hassannia H, Hojjat-Farsangi M, Shahmohammadi Farid S, Hashemi V, Jadidi-Niaragh F. Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models. Life Sci 2022;288:120166. [PMID: 34813798 DOI: 10.1016/j.lfs.2021.120166] [Reference Citation Analysis]
2 Alemohammad H, Najafzadeh B, Asadzadeh Z, Baghbanzadeh A, Ghorbaninezhad F, Najafzadeh A, Safarpour H, Bernardini R, Brunetti O, Sonnessa M, Fasano R, Silvestris N, Baradaran B. The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer. Biomed Pharmacother 2021;146:112516. [PMID: 34906767 DOI: 10.1016/j.biopha.2021.112516] [Reference Citation Analysis]
3 Liang X, Mu M, Fan R, Zou B, Guo G. Functionalized chitosan as a promising platform for cancer immunotherapy: A review. Carbohydrate Polymers 2022;290:119452. [DOI: 10.1016/j.carbpol.2022.119452] [Reference Citation Analysis]
4 Prateeksha, Sharma VK, Liu X, Oyarzún DA, Abdel-Azeem AM, Atanasov AG, Hesham AE, Barik SK, Gupta VK, Singh BN. Microbial polysaccharides: An emerging family of natural biomaterials for cancer therapy and diagnostics. Semin Cancer Biol 2021:S1044-579X(21)00151-6. [PMID: 34062265 DOI: 10.1016/j.semcancer.2021.05.021] [Reference Citation Analysis]
5 Hajizadeh F, Masjedi A, Heydarzedeh Asl S, Karoon Kiani F, Peydaveisi M, Ghalamfarsa G, Jadidi-Niaragh F, Sevbitov A. Adenosine and adenosine receptors in colorectal cancer. Int Immunopharmacol 2020;87:106853. [PMID: 32755765 DOI: 10.1016/j.intimp.2020.106853] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Fang Y, Yu A, Ye L, Zhai G. Research progress in tumor targeted immunotherapy. Expert Opin Drug Deliv 2021;18:1067-90. [PMID: 33507117 DOI: 10.1080/17425247.2021.1882992] [Reference Citation Analysis]
7 Ashrafizadeh M, Delfi M, Hashemi F, Zabolian A, Saleki H, Bagherian M, Azami N, Farahani MV, Sharifzadeh SO, Hamzehlou S, Hushmandi K, Makvandi P, Zarrabi A, Hamblin MR, Varma RS. Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. Carbohydr Polym 2021;260:117809. [PMID: 33712155 DOI: 10.1016/j.carbpol.2021.117809] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
8 Allahyari SE, Hajizadeh F, Zekiy AO, Mansouri N, Gilan PS, Mousavi SM, Masjedi A, Hassannia H, Ahmadi M, Mohammadi H, Yousefi M, Izadi S, Zolbanin NM, Jafari R, Jadidi-Niaragh F. Simultaneous inhibition of CD73 and IL-6 molecules by siRNA-loaded nanoparticles prevents the growth and spread of cancer. Nanomedicine 2021;34:102384. [PMID: 33771704 DOI: 10.1016/j.nano.2021.102384] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Budi HS, Izadi S, Timoshin A, Asl SH, Beyzai B, Ghaderpour A, Alian F, Eshaghi FS, Mousavi SM, Rafiee B, Nikkhoo A, Ahmadi A, Hassannia H, Ahmadi M, Sojoodi M, Jadidi-Niaragh F. Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth. Nanomedicine 2021;34:102373. [PMID: 33667724 DOI: 10.1016/j.nano.2021.102373] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Liu Y, Liu Y, Xu D, Zang J, Zheng X, Zhao Y, Li Y, He R, Ruan S, Dong H, Gu J, Yang Y, Cheng Q, Li Y. Targeting the Negative Feedback of Adenosine‐A2AR Metabolic Pathway by a Tailored Nanoinhibitor for Photothermal Immunotherapy. Advanced Science. [DOI: 10.1002/advs.202104182] [Reference Citation Analysis]
11 Bastaki S, Aravindhan S, Ahmadpour Saheb N, Afsari Kashani M, Evgenievich Dorofeev A, Karoon Kiani F, Jahandideh H, Beigi Dargani F, Aksoun M, Nikkhoo A, Masjedi A, Mahmoodpoor A, Ahmadi M, Dolati S, Namvar Aghdash S, Jadidi-Niaragh F. Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice. Life Sci 2021;266:118847. [PMID: 33309720 DOI: 10.1016/j.lfs.2020.118847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Kotulová J, Hajdúch M, Džubák P. Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose? Int J Mol Sci 2021;22:12569. [PMID: 34830449 DOI: 10.3390/ijms222212569] [Reference Citation Analysis]